5PSQ-216 Implementation of a medication reconciliation programme as a patient safety strategy

M. M. Sevilla, B. Rubio-Cebrián, ML De La Cruz Conty, B. Bartolomé, C. Moriel-Sánchez
{"title":"5PSQ-216 Implementation of a medication reconciliation programme as a patient safety strategy","authors":"M. M. Sevilla, B. Rubio-Cebrián, ML De La Cruz Conty, B. Bartolomé, C. Moriel-Sánchez","doi":"10.1136/EJHPHARM-2021-EAHPCONF.335","DOIUrl":null,"url":null,"abstract":"Background and importance Medication errors (ME) are especially frequent in hospital emergency departments (ED). To minimise these ME, medication reconciliation programmes are established, which analyse and resolve the discrepancies detected in the medication regimen of the patient. Aim and objectives To evaluate implementation of the reconciliation programme in the ED of a second level general hospital. Material and methods An observational retrospective study was conducted. Records from patients admitted to the observation area of the ED from 1 January 2018 to 31 March 2019 and whose chronic medication was reconciled were studied. Information related to their chronic medication was collected from the hospital medical records, the primary care prescriptions and/or through an interview with the patient. Discrepancies were classified according to the SEFH consensus document, and categorisation of the potential harm associated with these ME was based on the NCCMERP index; the pharmacotherapeutic groups involved in these ME were also analysed. Results 26.7% of patients admitted to the ED during the study period were reconciliated (780/2921), with a mean of 10.14 medications per patient. A mean of 1.6 discrepancies per patient were detected; 40.52% were ME, two thirds of which resulted from the omission of chronic medication and 72.15% of errors reached the patient but did not cause harm. The drugs involved in a higher proportion of ME were drugs to treat cardiovascular disorders. From the total amount of pharmaceutical interventions performed, 49.25% were accepted by physicians. Conclusion and relevance Due to the high average chronic drug intake of patients attending the ED and, therefore, the potential risk of ME, collaboration between physicians and pharmacists is crucial to ensure reconciled medication of patients, as a patient safeguard strategy and a standard of quality within the health system. References and/or acknowledgements No Conflict of interest No conflict of interest","PeriodicalId":11998,"journal":{"name":"European Journal of Hospital Pharmacy","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and importance Medication errors (ME) are especially frequent in hospital emergency departments (ED). To minimise these ME, medication reconciliation programmes are established, which analyse and resolve the discrepancies detected in the medication regimen of the patient. Aim and objectives To evaluate implementation of the reconciliation programme in the ED of a second level general hospital. Material and methods An observational retrospective study was conducted. Records from patients admitted to the observation area of the ED from 1 January 2018 to 31 March 2019 and whose chronic medication was reconciled were studied. Information related to their chronic medication was collected from the hospital medical records, the primary care prescriptions and/or through an interview with the patient. Discrepancies were classified according to the SEFH consensus document, and categorisation of the potential harm associated with these ME was based on the NCCMERP index; the pharmacotherapeutic groups involved in these ME were also analysed. Results 26.7% of patients admitted to the ED during the study period were reconciliated (780/2921), with a mean of 10.14 medications per patient. A mean of 1.6 discrepancies per patient were detected; 40.52% were ME, two thirds of which resulted from the omission of chronic medication and 72.15% of errors reached the patient but did not cause harm. The drugs involved in a higher proportion of ME were drugs to treat cardiovascular disorders. From the total amount of pharmaceutical interventions performed, 49.25% were accepted by physicians. Conclusion and relevance Due to the high average chronic drug intake of patients attending the ED and, therefore, the potential risk of ME, collaboration between physicians and pharmacists is crucial to ensure reconciled medication of patients, as a patient safeguard strategy and a standard of quality within the health system. References and/or acknowledgements No Conflict of interest No conflict of interest
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
5PSQ-216将药物和解方案作为患者安全战略的实施
背景与重要性药物错误(ME)在医院急诊科尤为常见。为了尽量减少这些ME,建立了药物调和方案,分析和解决在患者的药物治疗方案中发现的差异。目的和目的评价某二级综合医院急诊科和解方案的实施情况。材料与方法采用观察性回顾性研究。研究了2018年1月1日至2019年3月31日入住急诊科观察区的患者记录,并对其慢性药物进行了调和。从医院医疗记录、初级保健处方和/或通过对患者的访谈收集与他们的慢性药物有关的信息。根据SEFH共识文件对差异进行分类,并根据NCCMERP指数对这些ME相关的潜在危害进行分类;并对这些ME所涉及的药物治疗组进行分析。结果在研究期间,26.7%的急诊科患者(780/2921)进行了调解,平均每位患者使用10.14种药物。平均每位患者检测到1.6个差异;40.52%为ME,其中三分之二是由于遗漏慢性用药造成的,72.15%的错误到达患者但未造成伤害。与ME相关的较高比例的药物是治疗心血管疾病的药物。在实施的药物干预措施总量中,医生接受的占49.25%。由于急诊科患者的平均慢性药物摄入量较高,因此存在ME的潜在风险,医生和药剂师之间的合作对于确保患者的协调用药至关重要,这是一种患者保障策略和卫生系统内的质量标准。无利益冲突无利益冲突
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pharmacoeconomic and clinical impact of pharmaceutical service in the intensive care unit: a systematic review Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques Comparative analysis of the prevalence 3-HIT concept in people living with HIV and seronegative patients with chronic conditions. Cross-3HIT Project. Adverse drug effect in the context of drug shortage: the CIRUPT prospective study from the French pharmacovigilance network Investigation of the hospital pharmacy profession in Europe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1